Plus, during and before and after each knock on your door I got to thinking, and I don't deserve therapy.
"Most everyone involved in treating AIDS believes that prevention is more important yet feels that the millions of infected people deserve therapy," said Dr. Sande, who resigned as chairman of medicine at the University of Utah to commute to Uganda from Salt Lake City to direct the Academic Alliance for AIDS Care and Prevention in Africa.
TIL assessment could identify a subset of TIL− TN and HER2+ BC patients who deserve additional therapy.
You do NOT deserve abusive therapy, and the fact that you're disabled doesn't make it okay.
As recently recommended by the NICE guidelines [ 13], paediatricians while deciding who deserves antitubercular therapy, still have to consider clinical and epidemiological data.
First, interventions to reduce selection of resistant organisms include the following: (i) Overall reduction of antibiotic use in humans, animals and agriculture; early diagnosis of bacterial and viral diseases and infection severity will benefit the identification of situations deserving antibiotic therapy (http://ec.europa.eu/health/antimicrobial_resistance/policy/index_en.htm).htm
The efficacy of agents with potential immunomodulating effects, including intravenous immunoglobulin, N-acetylcysteine, acute use of statins, macrolides, peroxisome proliferator-activated receptors agonists, celecoxib and mesalazine, and the role of plasmapheresis and hemoperfusion as rescue therapy, deserve more investigation and where feasible, studies by RCTs.
The hypotheses generated, such as the role as a predictive marker for targeted therapy, deserve further investigation.
Two topics, contrast-induced AKI and management of renal replacement therapy, deserve special attention because of the frequency in which they are encountered and the availability of evidence.
The relationships of c Kit expression and mutations, and patients' response to imatinib-tailored therapy deserve further investigation in conjunction with clinical trials to gain deeper insight into pathways of c Kit regulation and signalling in breast cancer.
Academic institutions are in a much better position than pharmaceutical companies to make the best decisions about which therapies deserve further development.
